PHASE II STUDY OF THE COMBINATION OF BEVACIZUMAB (RHUMAB VEGF) AND OXALIPLATIN PLUS CAPECITABINE (XELOX) IN PATIENTS WITH ADVANCED COLORECTAL CANCER

被引：0
|
作者：
Sarmiento, R. [1 ]
Frustaci, S. [2 ]
Torino, F. [3 ]
Ravaioli, A. [4 ]
Mattioli, R. [5 ]
Gebbia, V. [6 ]
Veri, A. [3 ]
Gasparini, G. [7 ]
机构：
[1] San Filippo Neri, Oncol, Rome, Italy
[2] Ctr Riferimento Oncol, Med Oncol B, I-33081 Aviano, Italy
[3] Aco San Filippo Neri, Med Oncol B, Rome, Italy
[4] Osped Infermi, Rimini, Italy
[5] Osped Santa Croce, Fano, Italy
[6] Osped Rinuniti Alta Specializzaz Maddalena, Palermo, Italy
[7] San Filippo Neri Hosp, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [41] Oxaliplatin plus raltitrexed in the treatment of patients with advanced colorectal cancer: A phase II study
    Martoni, A
    Mini, E
    Pinto, C
    Gentile, AL
    Nobili, S
    Dentico, P
    Marino, A
    Scicolone, S
    Angelelli, B
    Mazzei, T
    [J]. ANTICANCER RESEARCH, 2003, 23 (1B) : 687 - 691
  • [42] Chronomodulated Administration of Oxaliplatin plus Capecitabine (XELOX) as First Line Chemotherapy in Metastatic Colorectal Cancer Patients: Phase II Brunch Regimen Study.
    Pilanci, Kezban Nur
    Saglam, Sezer
    Okyar, Alper
    Yucel, Serap
    Kara, Zeliha Pala
    Ordu, Cetin
    Namal, Esat
    Ciftci, Rumeysa
    Koksal, Ulkuhan
    Saglam, Esra Kaytan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [43] RANDOMIZED PHASE II STUDY OF OXALIPLATIN AND S-1 (OS) VERSUS OXALIPLATIN AND CAPECITABINE (XELOX) IN PATIENTS WITH METASTATIC OR RECURRENT COLORECTAL CANCER
    Zang, D. Y.
    Chung, I. J.
    Oh, H.
    Park, K. U.
    Lee, K. H.
    Han, B.
    Choi, D. R.
    Kim, H. S.
    Kim, J. H.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 193 - 193
  • [44] Secondary resectability rates observed in a multicenter randomized phase II study of modified capecitabine/ irinotecan (mXELIRI) plus bevacizumab (bev) followed by capecitabine/oxaliplatin (XELOX) plus bev or the reverse sequence in patients with metastatic colorectal cancer (mCRC)
    Scheithauer, W.
    Prager, G.
    Greil, R.
    Mlineritsch, B.
    Schaberl-Moser, R.
    Gerger, A.
    Laengle, F.
    Viragos-Toth, I.
    Andel, J.
    Pichler, A.
    Pecherstorfer, M.
    Kretschmer, A.
    Seebacher, A.
    Jagdt, B.
    Eisterer, W.
    Krippl, P.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [45] Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients
    Coskun, U.
    Buyukberber, S.
    Yaman, E.
    Uner, A.
    Er, O.
    Ozkan, M.
    Dikilitas, M.
    Oguz, M.
    Yildiz, R.
    Yamac, D.
    Ozturk, B.
    Kaya, A. O.
    Benekli, M.
    [J]. NEOPLASMA, 2008, 55 (01) : 65 - 70
  • [46] Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer
    Emel Yaman
    Aytug Uner
    Ozlem Er
    Ugur Coskun
    Suleyman Buyukberber
    Mustafa Dikilitas
    Mevlude Polat
    Deniz Yamac
    Ali Osman Kaya
    Ramazan Yildiz
    Banu Ozturk
    Mustafa Benekli
    [J]. Medical Oncology, 2007, 24 : 431 - 435
  • [47] Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer
    Yaman, Emel
    Uner, Aytug
    Er, Ozlem
    Coskun, Ugur
    Buyukberber, Suleyman
    Dikilitas, Mustafa
    Polat, Mevlude
    Yamac, Deniz
    Kaya, Ali Osman
    Yildiz, Ramazan
    Ozturk, Barm
    Benekli, Mustafa
    [J]. MEDICAL ONCOLOGY, 2007, 24 (04) : 431 - 435
  • [48] WEEKLY OXALIPLATIN AND CAPECITABINE CONTINUOUSLY IN ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER (ACRC). A PHASE II STUDY
    Pochettino, Paolo
    Bergnolo, Paola
    Boglione, Antonella
    Dal Canton, Orietta
    Cutin, Simona Chiado
    Garetto, Ferdinando
    Biscardi, Emanuela
    Comandone, Alessandro
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 61 - 61
  • [49] Oxaliplatin/Capecitabine combination (Xelox) with or without targeted therapies in advanced colorectal cancer (ACRC) and pharmacokinetic analysis
    Gil-Delgado, M.
    Bastian, G.
    Spano, J.
    Paule, B.
    Des-Guetz, G.
    Bardier-Dupas, A.
    Khayat, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205
    T Hoehler
    G von Wichert
    C Schimanski
    S Kanzler
    M H Moehler
    A Hinke
    T Seufferlein
    J Siebler
    A Hochhaus
    D Arnold
    M Hallek
    R Hofheinz
    U T Hacker
    [J]. British Journal of Cancer, 2013, 109 : 1408 - 1413
12345